Mr. President, you should learn more about diversity
By MARK CRONIN // In times of tragedy, our words matter. We witnessed 67 people lose their lives, suddenly tossing mothers, fathers, brothers, sisters, friends, coworkers and teammates into the…
Down syndrome
‘Dormant’ biotech wakes on Alzheimer’s fast track
By GREGORY ZELLER // A pre-clinical-stage biopharmaceutical company is being fast-tracked toward a potential Alzheimer’s treatment, after taking a decidedly slow road. Stony Brook-based Avanti Biosciences Inc. actually launched in…